FDA: Recall of potassium phosphate and succinylcholine chloride by PharMEDium Services

Editor's Note

The Food and Drug Administration on June 27 announced the recall by PharMEDium Services of specific lots of potassium phosphate and succinylcholine chloride because of a lack of sterility assurance.

The products being recalled were compounded using certain Hospira products, which were recalled on June 15 because microbial growth was found during a routine simulation of the manufacturing process.

Posted 06/27/2017] AUDIENCE: Pharmacy ISSUE: PharMEDium Services is conducting a limited, voluntary recall due to Hospira Inc.'s ("Hospira") June 15, 2017 recall announcement that microbial growth was detected during a routine simulation of the manufacturing process and therefore there was a lack of sterility assurance.